Page 7 of 9
Organic & Biomolecular Chemistry
Please do not adjust margins
Journal Name
ARTICLE
C6H2), 6.36 (d, J = 7.8 Hz, 1H, 5-H), 6.28 (dd, J = 6.0, 8.4 Hz, 1H, 1′-
H), 4.97-4.87 (m, 2H, OCH2C6H2), 4.60-4.57 (m, 1H, 3′-H), 4.54-4.51
(m, 1H, 4′-H), 4.32-4.21 (m, 2H, 5′-H), 3.98 (s, 3H, one of CH3O),
-2′-deoxyguanosine
DOI: 10.1039/C6OB01371F
To a solution of 6-Chloro-2-[(dimethylaminomethylene)amino]-
3.93 (s, 3H, one of CH3O), 2.74-2.69 (m, 1H, one of 2′-H), 2.39-2.32 9-[β-D-5′-O-(tert–butyl dimethyl silyl) - 3′ - O - ( 4,5-dimethoxy -2-
(m, 1H, one of 2′-H); 13C NMR (150.8 MHz, D2O) 159.0, 152.8,
nitrobenzyl)-2′-deoxyribofuranosyl]purine 3.4b (1.23 g, 1.89 mmol)
in anhydrous DMF (12.0 mL) were added cesium acetate (1.09 g, 5.68
mmol), 1,4-diazabicyclo[2.2.2]octane (DABCO) (0.212 g, 1.89
mmol) and triethylamine (0.790 mL, 5.68 mmol) under argon and
stirred overnight at room temperature with exclusion of air and light.
Ac2O (5.4 mL) was added to the above reaction mixture and stirred
for another 30 min. The reaction mixture was then quenched with
water (20 mL) and extracted with ethyl acetate (3x50 mL). The
organic layer was dried over Na2SO4. After evaporation, the crude
product was purified by flash column chromatography over silica gel
using MeOH/DCM (1:20) to afford compound 3.5b as a pale yellow
solid (0.52 g, 44%). 1H NMR (600 MHz, CDCl3) δ 8.65 (s, 1H, NH),
8.61 (s, 1H, CHN(CH3)2), 7.90 (s, 1H, 8-H), 7.73 (s, 1H, one of C6H2),
7.25 (s, 1H, one of C6H2), 6.39 (dd, J = 5.4, 8.4 Hz, 1H, 1′-H), 5.05-
4.92 (m, 2H, OCH2C6H2), 4.45-4.42 (m, 1H, 3′-H), 4.29-4.26 (m, 1H,
4′-H), 4.02 (s, 3H, one of CH3O), 3.97 (s, 3H, one of CH3O), 3.87-
3.79 (m, 2H, 5′-H), 3.18 (s, 3H, one of N(CH3)2), 3.10 (s, 3H, one of
N(CH3)2), 2.70-2.65 (m, 1H, one of 2′-H), 2.60-2.54 (m, 1H, one of
2′-H), 0.91 (s, 9H, C(CH3)3), 0.10 (s, 6H, two of SiCH3).
148.0, 146.7, 144.2, 138.6, 128.9, 110.1, 107.5, 95.0, 86.8, 84.1, 80.6,
67.6, 58.4, 56.0, 55.7, 37.3. 31P NMR (242.7 MHz, D2O) δ -10.6 (brs,
-
2P), -23.0 (brs, 1P); HRMS (ES-) calcd for C18H24N4O17P3 [(M+3H)]:
661.0355, found: 661.0356; HPLC: 93.3%.
3. Synthesis of 3′ -O- (2-nitrobenzyl) -2′- deoxyguanosine -5′-
triphosphate
(NB-dGTP)
and
3′-O-(4,5-dimethoxy-2-
nitrobenzyl)- 2′-deoxyguanosine-5′-triphosphate (DMNB-dGTP)
3.6b. Synthesis of N2-[(dimethylamino)methylene]-3′-O-(4,5-
dimethoxy-2-nitrobenzyl)-2′-deoxyguanosine.
To an ice cold solution of 5′-O-(t-butyldimethylsilyl)-N2-
[(dimethylamino)methylene]-3′-O-(4,5-dimethoxy-2-nitrobenzyl)-2′-
deoxyguanosine 3.5b (0.51 g, 0.70 mmol) in THF (6.0 mL) was added
1.0 M TBAF in THF solution (1.6 mL, 1.6 mmol) over 1 min. The
reaction mixture was allowed to warm to room temperature and stirred
for 2.5 h with exclusion of air and light, diluted with EtOAc (100 mL),
washed with water (15 mL), brine (15 mL) and dried over anhydrous
Na2SO4. After concentration of the filtrate, the residue was purified
by flash column chromatography over silica gel using MeOH/DCM
Scheme 4: Synthesis of NB-dGTP and DMNB-dGTP
3.4b. Synthesis of 6-Chloro-2-[(dimethylaminomethylene) amino]
-9- [ β-D -5′ -O- (tert-butyldimethylsilyl) -3′- O- (4,5-dimethoxy -
2-nitrobenzyl)-2′-deoxyribofuranosyl] purine.
To
an
ice
cold
solution
of
6-chloro-2-
1
(1: 20) to afford 3.6b (0.350 g, 85%) as yellow solid. H NMR (600
[(dimethylaminomethylene)amino]-9- [β-D-5′-O-(tert-butyldimethyl
silyl) -2′-deoxyribofur anosyl] purine 3.310 (2.50 g, 5.50 mmol) in
anhydrous THF (25 mL) was added 95% NaH powder (0.306 g, 12.1
mmol) in portions. After stirring for 50 min at room temperature, a
solution of 4,5-dimethoxy-2-nitrobenzyl bromide (3.04 g, 11.0 mmol)
in THF (5.0 mL) was added, and then the reaction mixture was stirred
for another 2.5 h at room temperature with exclusion of air and light.
After concentration, the resulting residue was dissolved in ethyl
acetate (250 mL), washed with saturated aqueous NaHCO3 (20 mL),
brine (20 mL) and dried over anhydrous Na2SO4. After concentration,
the crude product was purified by flash column chromatography over
silica gel using EtOAc/hexanes (1:1-2:1) to afford compound 3.4b as
a pale yellow foam (1.25 g, 35%). 1H NMR (600 MHz, CDCl3) δ 8.74
(s, 1H, CHN(CH3)2), 8.28 (s, 1H, 8-H), 7.73 (s, 1H, one of C6H2), 7.27
(s, 1H, one of C6H2), 6.66 (dd, J = 6.0, 8.4 Hz, 1H, 1′-H), 4.98-4.92
(m, 2H, OCH2C6H2), 4.42-4.36 (m, 1H, 3′-H), 4.32-4.27 (m, 1H, 4′-
H), 4.05 (s, 3H, one of CH3O), 3.97 (s, 3H, one of CH3O), 3.93-3.84
(m, 2H, 5′-H), 3.18 and 3.17 (s, 6H, N(CH3)2), 2.78-2.73 (m, 1H, one
of 2′-H), 2.50-2.44 (m, 1H, one of 2′-H), 0.92 (s, 9H, C(CH3)3), 0.13
(s, 3H, one of SiCH3), 0.12 (s, 3H, one of SiCH3).
MHz, DMSO-d6) δ 11.3 (s, 1H, NH), 8.56 (s, 1H, CHN(CH3)2), 8.04
(s, 1H, 8-H), 7.67 (s, 1H, one of C6H2), 7.29 (s, 1H, one of C6H2), 6.25
(dd, J = 6.0, 8.4 Hz, 1H, 1′-H), 5.04 (t, J = 6.0 Hz, 1H, OH), 4.94-4.86
(m, 2H, OCH2C6H2), 4.35-4.31 (m, 1H, 3′-H), 4.10-4.06 (m, 1H, 4′-
H), 3.92 (s, 3H, one of CH3O), 3.85 (s, 3H, one of CH3O), 3.60-3.52
(m, 2H, 5′-H), 3.12 (s, 3H, one of N(CH3)2), 3.01 (s, 3H, one of
N(CH3)2), 2.76-2.60 (m, 1H, one of 2′-H), 2.54-2.48 (m, 1H, one of
2′-H overlapped with DMSO signal).
DMNB-dGTP. Synthesis of 3′-O-(4,5-dimethoxy-2-nitrobenzyl)-
2′-deoxyguanosine-5′-triphosphate.
Using the same preparation procedure of DMNB-dATP,
compound
3′-O-(4,5-dimethoxy-2-nitrobenzyl)-dGTP
was
1
obtained as a pale yellow gum of TEA salt (118 mg, 35%). H NMR
(600 MHz, D2O) δ 8.11 (s, 1H, 8-H), 7.71 (s, 1H, one of C6H2), 7.23
(s, 1H, one of C6H2), 6.29-6.25 (m, 1H, 1′-H), 5.02-4.89 (m, 2H,
OCH2C6H2), 4.69-4.64 (m, 1H, 3′-H), 4.53-4.47 (m, 1H, 4′-H), 4.25-
4.13 (m, 2H, 5′-H), 3.99 (s, 3H, one of CH3O), 3.93 (s, 3H, one of
CH3O), 2.87-2.71 (m, 2H, 2′-H); 13C NMR (150.8 MHz, D2O)
158.1, 153.4, 152.9, 146.8, 146.7, 138.6, 138.4, 129.1, 129.0, 110.2,
107.5, 83.9, 83.6, 80.6, 67.8, 58.5, 56.1, 56.8, 36.2. 31P NMR (242.7
3.5b.
Synthesis
of
5′-O-(t-butyldimethylsilyl)-N2-
This journal is © The Royal Society of Chemistry 20xx
Organic & Biomolecular Chemistry., 2016, 00, 1-3 | 7
Please do not adjust margins